CSS
WGS icon

Cubist Systematic Strategies’s GeneDx Holdings WGS Stock Holding History

Cubist Systematic Strategies’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.65M Sell
24,600
-9,900
-29% -$1.08M 0.01% 1382
2025
Q2 		$3.18M Buy
34,500
+11,100
+47% +$871K 0.01% 1298
2025
Q1 		$2.07M Sell
23,400
-2,700
-10% -$234K 0.01% 1394
2024
Q4 		$2.01M Buy
26,100
+18,700
+253% +$1.31M 0.01% 1347
2024
Q3 		$314K Buy
+7,400
New +$250K ﹤0.01% 2408

Other funds holding WGS

CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Cubist Systematic Strategies's WGS Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of GeneDx Holdings (WGS) in Q1 2025, closing a stake of 22,804 shares — an estimated $1.98M sold.

Cubist Systematic Strategies first reported a position in WGS in Q3 2021 and held it in 9 quarters. The position peaked at $5.29M in Q3 2024. 225 funds tracked by Wall St. Rank hold WGS as of Q1 2025.

  • Cubist Systematic Strategies reported no remaining GeneDx Holdings position as of Q1 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 22,804 GeneDx Holdings shares in Q1 2025, an estimated $1.98M.
  • Cubist Systematic Strategies first reported a position in GeneDx Holdings in Q3 2021 and held it in 9 quarters.
  • Cubist Systematic Strategies's GeneDx Holdings position peaked at $5.29M in Q3 2024.
  • 225 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.